Autism Diagnostic Observation Schedule (ADOS-2) Administration Training -- Florence, KY

When Mar 29, 2018 08:00 AM to
Mar 30, 2018 04:30 PM
Where Ralph Rush Staff Development Center, 99 Center Drive, Florence, KY 41042
Contact Name
Contact Phone (502)852-2467
Add event to calendarvCal

Registration begins at 8:00 AM Eastern Time


The Autism Diagnostic Observation Schedule, Second Edition (ADOS-2) is a semi-structured, standardized measure of communication, social interaction, play/imagination, and restricted and/or repetitive behaviors published by Western Psychological Services. The ADOS-2 is often referred to as the “gold standard” measure of observational assessment for autism spectrum disorder.

Individuals who can administer the ADOS-2 are clinical and school psychologists, psychiatrists, developmental pediatrician, occupational therapists, and speech pathologists that have prior education, training, and experience in conducting individually administered test batteries and, training by an independent trainer or the test publisher is required.


Pending Continuing Education

Continuing Education Approval is being requested from each of the professional organizations listed below:

Kentucky Licensure Board of Speech Language Pathology -- APPROVED

Kentucky Licensure Board of Occupational Therapy--APPROVED

Kentucky Board of Licensed Professional Counselors -- PENDING

Kentucky Board of Psychology -- PENDING

Kentucky Association for Psychology in the Schools --APPROVED

Kentucky Board of Social Work -- APPROVED


Rachel Hundley, Ph.D.

Assistant Professor of Pediatrics, Division of Developmental Medicine; Assistant Professor of Psychiatry; Psychologist, Vanderbilt Kennedy Center Learning Assessment Clinic

As a trainer for the Autism Diagnostic Observation Schedule, she has taught this measure nationally and internationally. In clinical settings, she has mentored postdoctoral fellows in psychology as well as psychology graduate and undergraduate students. Her previous research has primarily focused on social development and developmental disabilities, including autism and genetic disorders. At Vanderbilt, she is contributing to a study assessing the cognitive, behavioral, and neural components of Angelman syndrome, Rett syndrome, and MeCP2 duplication, and to a study of sleep intervention for children with ASD. She is part of the Autism Treatment Network (ATN), and she represents Vanderbilt on the Behavioral Sciences Committee for the ATN. She will soon begin working with colleagues at Vanderbilt and in Boston to examine the efficacy of a new medicine designed to address neurodevelopment and abnormal movements in Angelman syndrome.


More information about this event…